Persistent URL of this record https://hdl.handle.net/1887/3567822
Documents
-
- Download
- 1-s2.0-S2213858722000432-main
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
- All authors
- Ostadal, P.; Steg, P.G.; Poulouin, Y.; Bhatt, D.L.; Bittner, V.A.; Chua, T.; Diaz, R.; Goodman, S.G.; Huo, Y.; Jukema, J.W.; Karpov, Y.; Pordy, R.; Scemama, M.; Szarek, M.; White, H.D.; Schwartz, G.G.; ODYSSEY OUTCOMES Investigators
- Date
- 2022-04-21
- Volume
- 10
- Issue
- 5
- Pages
- 330 - 340